title: Reduction of high-fat diet-induced obesity after chronic administration of brain-derived neurotrophic factor in the hypothalamic ventromedial nucleus.
abstract: An acute injection of brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus (VMN) decreases body weight by reducing feeding and increasing energy expenditure (EE) in animals on standard laboratory chow. Animals have divergent responses to high-fat diet (HFD) exposure, with some developing obesity and others remaining lean. In the current study, we tested the hypothesis that BDNF in the VMN reduces HFD-induced obesity. Seventy-two 10-week old rats were allowed HFD ad libitum for 8 weeks and then prepared with bilateral VMN cannulae. Animals were then divided into tertiles based on their fat mass rank: high, intermediate, and low (H, I, and L). Each group was further divided into two subgroups: BDNF (1 μg) or control (artificial cerebrospinal fluid, aCSF); they were then injected every other day for 20 days according to subgroup. Energy intake, body weight, and body composition were measured. Other metabolic indexes were measured before and after treatment. In parallel, another 12 rats were fed control diet (CD), VMN-cannulated, and injected with aCSF. HFD exposure induced obesity in the H group, with a significant increase in energy intake, body weight, fat mass, liver size, and serum glucose, insulin, and leptin. BDNF significantly reduced body weight and fat mass in all phenotypes, while it reduced energy intake only in the I group. However, BDNF increased EE, spontaneous physical activity, and fat oxidation in the H group, suggesting that BDNF-induced EE elevation contributed to reduction of body weight and fat mass. Chronic VMN BDNF reduced insulin elevation and/or reversed hyperleptinemia. These data suggest that the VMN is an important site of action for BDNF reduction of HFD-induced obesity.
authors.affiliation: Veterans Affairs Medical Center, One Veterans Drive, Research Route 151, Minneapolis, MN 55417, USA.
authors.forename: R
authors.initials: R
authors.lastname: Godar
authors.forename: Y
authors.initials: Y
authors.lastname: Dai
authors.forename: H
authors.initials: H
authors.lastname: Bainter
authors.forename: C
authors.initials: C
authors.lastname: Billington
authors.forename: C M
authors.initials: CM
authors.lastname: Kotz
authors.forename: C F
authors.initials: CF
authors.lastname: Wang
mesh_terms: D000273:Adipose Tissue / Q000502:physiology; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000502:physiology* / Q000627:therapeutic use; D000075202:Contraindications; D059305:Diet, High-Fat / Q000009:adverse effects*; D004195:Disease Models, Animal; D002149:Energy Intake / Q000502:physiology; D006946:Hyperinsulinism / Q000517:prevention & control; D020738:Leptin / Q000037:antagonists & inhibitors / Q000097:blood; D008297:Male; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014697:Ventromedial Hypothalamic Nucleus / Q000378:metabolism* / Q000502:physiology
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D020738:Leptin